Drug Carrier

Drug Carrier refers to delivery vehicles or platforms that transport therapeutic agents to target sites, protecting drugs during transit, controlling release kinetics, enhancing bioavailability, or enabling tissue-specific targeting that improves therapeutic efficacy while reducing side effects. These sophisticated systems encompass diverse technologies including liposomes, polymeric nanoparticles, micelles, dendrimers, antibody-drug conjugates, and other constructs that modify drug pharmacokinetics, biodistribution, and cellular uptake compared to free drug administration.

The pharmaceutical industry employs drug carrier technologies addressing formulation challenges and therapeutic optimisation across multiple modalities. Lipid-based carriers including liposomes protect drugs from degradation, enable intravenous administration of poorly soluble compounds, and can incorporate targeting ligands. Polymer-based systems provide sustained release maintaining therapeutic concentrations over extended periods from single administrations, improving patient compliance while reducing dosing frequency. Antibody-drug conjugates represent sophisticated carriers using monoclonal antibodies delivering potent cytotoxic payloads specifically to tumour cells expressing target antigens. Nanoparticle carriers enable mRNA vaccine delivery protecting fragile nucleic acids while facilitating cellular uptake and intracellular release. As precision medicine advances and therapeutic molecules diversify, drug carrier technologies continue evolving through stimuli-responsive systems, biomimetic approaches, and multifunctional carriers combining targeting, imaging, and therapeutic delivery within integrated platforms.